With over 40 years of clinical heritage, the Oxford® Partial Knee is the most widely used1 and clinically proven2,3 partial knee system in the world.

Could you be treating your patients with a Partial Knee Replacement?

Research shows that 47.6% of knee replacement patients are actually candidates for partial knee arthroplasty (PKA)4 and  after one year, a randomized, controlled study showed that significantly more partial knee patients would have the operation again compared to total knee patients5.

Furthermore, Liddle, AD. et al., found that surgeons utilizing PKR for under 20% of their annual knee replacements experienced an increase in their revision rate.6

  1. Data on file at Zimmer Biomet. Based on Market Analysis and Registry Data, gathered September 2017.
  2. Price, A. and Svard, U. A Second Decade Lifetable Survival Analysis of the Oxford Unicompartmental Knee Arthroplasty. Clinical Orthopaedics and Related Research. Published Online 13 August 2010.
  3. Pandit et al. The clinical outcome of minimally invasive phase 3 Oxford unicompartmental knee arthroplasty. Bone Joint J 2015;97-B:1493–1500.
  4. Willis-Owen, et al. Unicondylar knee arthroplasty in the UK National Health Service: An analysis of candidacy, outcome and cost efficacy. ScienceDirect. The Knee 16. 473–478. 2009
  5. Beard D, Price A, Davies L, et al. A Multicentre Randomised Study Comparing Total or Partial Knee Replacement – One Year Results of The Topkat Trial. BASK. Liverpool, UK 2016.
  6. Liddle, AD, et al. Optimal usage of unicompartmental knee arthroplasty. Bone Joint J 2015;97-B:1506–11.